Growth via merger Renal Advantage has recently merged with Liberty Dialysis, creating the third largest outpatient dialysis provider in the US. This presents cross-sell opportunities for ancillary services, network expansion capabilities, and enhanced bargaining power with suppliers and payers.

Expanded footprint With 156 dialysis centers in 18 states and a patient base around 12,000, there is substantial geographic spread to target for additional services, partner programs, and regional laboratory or support services scaling.

Integrated lab services RenaLab operates as a state-of-the-art independent clinical laboratory. This creates potential for data-driven partnerships, expanded specimen processing, and added value services that leverage laboratory capabilities across the network.

Revenue scale Current revenue sits in the mid-range for the sector, indicating room to increase wallet share through enhanced patient management solutions, ancillary care programs, and enterprise software that improves efficiency and outcomes.

Market positioning As a large multi-state dialysis provider with a sizable patient base, Renal Advantage is well positioned to pursue partnerships with payers, purchase agreements for equipment and consumables, and scalable service offerings that can be standardized across centers.